Report
Clément Bassat

PORTZAMPARC MIDCAP MIDDAY - 2023-06-19

BIOCORP : Acquisition by Novo Nordisk - Management contact - Hold (3) vs Strong Buy (1), Target Price: 35.0€
Price: 34.0€ at 16/06/23
BIOSENIC: Failure of ALLOB phase 2b trial inherited from Bone Therapeutics - Strong Buy (1), Target Price: €0.35
Price: €0.11 on 16/06/23
MITHRA: Reduce its stake in Mayne Pharma - Strong Buy (1), Target Price: 4.10€
Price: 2.63€ at 16/06/23
Underlyings
Biocorp Production SA

Biocorp Production SA is a France-based company, which is specialised in the development and manufacturing of medical and drug delivery devices.

Bone Therapeutics SA

Bone Therapeutics is a biotechnology company with an advanced clinical pipeline of cell products for orthopaedic conditions and bone diseases (two Phase II/III and three Phase I/II clinical studies). These areas are characterized by high unmet medical needs due to the lack of efficacious and safe, non-invasive, treatments. Co. has two products in clinical trials, its allogeneic bone cell therapy product, ALLOB®, and its autologous bone cell therapy product, PREOB®. Co. is also conducting preclinical research on next generation products, such as combined cell-matrix products for large bone defects and maxillofacial.

N.V. Mithra Pharmaceuticals S.A.

Mithra Pharmaceuticals SA is a Belgium-based company active in the pharmaceutical industry. The Company is dedicated to provide products and services for the fertility, contraception and menopause of women. It has a number of patent families regarding Estetrol (E4), a natural estrogen produced by the human foetus, which enables the investigation of fertility and contraception products. Mithra is focused on the development of two late-stage E4-based products: Estelle, a 5th generation oral contraceptive, and Donesta, a hormone therapy for Vasomotor Symptoms in menopause. Mithra develops a contraceptive vaginal ring called Myring and Zoreline, a biodegradable subcutaneous implant for hormone dependant cancer.

Provider
Portzamparc Sponsored
Portzamparc Sponsored

​Portzamparc is a subsidary of BNP Paribas which adapted the mission to contribute to responsible and sustainable growth of private clients, management companies and SMEs . They offer personalized support adapted to the objectives in particular for Small and Medium-Sized Enterprises.

Analysts
Clément Bassat

Other Reports on these Companies
Other Reports from Portzamparc Sponsored

ResearchPool Subscriptions

Get the most out of your insights

Get in touch